These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35802628)

  • 1. Dementia risk and dynamic response to exercise: A non-randomized clinical trial.
    Vidoni ED; Morris JK; Palmer JA; Li Y; White D; Kueck PJ; John CS; Honea RA; Lepping RJ; Lee P; Mahnken JD; Martin LE; Billinger SA
    PLoS One; 2022; 17(7):e0265860. PubMed ID: 35802628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A methodology for an acute exercise clinical trial called dementia risk and dynamic response to exercise.
    White D; John CS; Kucera A; Truver B; Lepping RJ; Kueck PJ; Lee P; Martin L; Billinger SA; Burns JM; Morris JK; Vidoni ED
    Sci Rep; 2021 Jun; 11(1):12776. PubMed ID: 34140586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerobic exercise improves hippocampal blood flow for hypertensive Apolipoprotein E4 carriers.
    Kaufman CS; Honea RA; Pleen J; Lepping RJ; Watts A; Morris JK; Billinger SA; Burns JM; Vidoni ED
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2026-2037. PubMed ID: 33509035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E4 Moderates the Association Between Vascular Risk Factors and Brain Pathology.
    Kaufman CS; Morris JK; Vidoni ED; Burns JM; Billinger SA
    Alzheimer Dis Assoc Disord; 2021 Jul-Sep 01; 35(3):223-229. PubMed ID: 33734100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
    Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden.
    Lin Z; Sur S; Soldan A; Pettigrew C; Miller M; Oishi K; Bilgel M; Moghekar A; Pillai JJ; Albert M; Lu H
    Radiology; 2019 Jul; 292(1):140-148. PubMed ID: 31012816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial.
    Park KS; Ganesh AB; Berry NT; Mobley YP; Karper WB; Labban JD; Wahlheim CN; Williams TM; Wideman L; Etnier JL
    BMC Neurol; 2020 Jun; 20(1):231. PubMed ID: 32503473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
    Fleisher AS; Chen K; Liu X; Ayutyanont N; Roontiva A; Thiyyagura P; Protas H; Joshi AD; Sabbagh M; Sadowsky CH; Sperling RA; Clark CM; Mintun MA; Pontecorvo MJ; Coleman RE; Doraiswamy PM; Johnson KA; Carpenter AP; Skovronsky DM; Reiman EM
    Neurobiol Aging; 2013 Jan; 34(1):1-12. PubMed ID: 22633529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
    Stanitsa E; Economou A; Beratis I; Kontaxopoulou D; Fragkiadaki S; Papastefanopoulou V; Pavlou D; Papantoniou P; Kroupis C; Papatriantafyllou J; Stefanis L; Yannis G; Papageorgiou SG
    J Alzheimers Dis; 2021; 84(3):1005-1014. PubMed ID: 34602476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHA brain uptake and APOE4 status: a PET study with [1-
    Yassine HN; Croteau E; Rawat V; Hibbeln JR; Rapoport SI; Cunnane SC; Umhau JC
    Alzheimers Res Ther; 2017 Mar; 9(1):23. PubMed ID: 28335828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
    Ercoli L; Siddarth P; Huang SC; Miller K; Bookheimer SY; Wright BC; Phelps ME; Small G
    Arch Gen Psychiatry; 2006 Apr; 63(4):442-8. PubMed ID: 16585474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered small-world anatomical networks in Apolipoprotein-E4 (ApoE4) carriers using MRI.
    Goryawala M; Zhou Q; Duara R; Loewenstein D; Cabrerizo M; Barker W; Adjouadi M
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2468-71. PubMed ID: 25570490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease.
    Adluru N; Destiche DJ; Lu SY; Doran ST; Birdsill AC; Melah KE; Okonkwo OC; Alexander AL; Dowling NM; Johnson SC; Sager MA; Bendlin BB
    Neuroimage Clin; 2014; 4():730-42. PubMed ID: 24936424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of apolipoprotein E ε4 allele, regional cerebral blood flow, and serum liver function markers in patients with cognitive impairment.
    Wang H; Shi L; Luo S; Luo Y; Xu C; Qiu G; Guo Q; Chen C; Lu T; Liu K; Zhu F
    Front Neurol; 2024; 15():1345705. PubMed ID: 38628697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular response to exercise interacts with individual genotype and amyloid-beta deposition to influence response inhibition with aging.
    Palmer JA; Kaufman CS; Vidoni ED; Honea RA; Burns JM; Billinger SA
    Neurobiol Aging; 2022 Jun; 114():15-26. PubMed ID: 35344819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the apolipoprotein E ε4 allele on functional MRI during n-back working memory tasks in healthy middle-aged adults.
    Chen CJ; Chen CC; Wu D; Chi NF; Chen PC; Liao YP; Chiu HW; Hu CJ
    AJNR Am J Neuroradiol; 2013; 34(6):1197-202. PubMed ID: 23275593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.
    Fouquet M; Besson FL; Gonneaud J; La Joie R; Chételat G
    Neuropsychol Rev; 2014 Sep; 24(3):290-9. PubMed ID: 25146994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.